Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes 21 Mar 2023 We have seen major advances in prostate cancer research, and people with the disease are living longer than ever. However, more needs to be done to harness scientific discoveries and bring innovative drugs to patients. Here we discuss the regulatory landscape and reforms needed to ensure patients can access the most innovative treatments as quickly as possible. Find out more Show/Hide
Access routes and asking prices - getting drugs to cancer patients 11 Nov 2020 Today the ICR and 15 organisations launch a nine point plan on cancer drug pricing and access. Here, our Policy Officer Joanne Duffy speaks to patient advocate Emma Robertson about the recommendations. Find out more Show/Hide
Making the case for ‘regulatory innovation’ in cancer research 02 Dec 2019 Regulation of new cancer therapies, whilst crucially important, can become a barrier to innovation. Our Policy Adviser, Roya Ziaie, takes a look at the current regulatory landscape and what is needed in the future to ensure innovative treatments find their way to patients as quickly as possible. Find out more Show/Hide
NCRI 2019: Making research count for patients – reflecting on a fascinating first day at the UK’s biggest cancer conference 04 Nov 2019